https://www.selleckchem.com/pr....oducts/bay-60-6583.h
l leads to improved patient outcomes, can overcome community stakeholder concerns, and is sustainable. Whether high burden of subclinical vascular disease (SVD) is associated with increased premature mortality among middle-aged adults is not adequately understood. The association of midlife SVD burden with premature mortality among middle-aged adults free of clinical cardiovascular disease (CVD) could provide further insights into stratifying premature death beyond clinical CVD. To determine whether high burden of subclinical vascul
Мне нравится
Комментарий
Перепост
